Skip to content
10-K

Annual Report

FURIEX PHARMACEUTICALS, INC.

0001437749-14-004302

← back to feed
Filed
Mar 17, 2014 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Outstanding FY 2013 · Feb 28, 2014 10.61M sh
Capex FY 2013 · Dec 31, 2013 $26K
Capex FY 2013 · Dec 31, 2012 $77K
Capex FY 2013 · Dec 31, 2011 $22K
Operating Cash Flow FY 2013 · Dec 31, 2013 −$23.14M
Operating Cash Flow FY 2013 · Dec 31, 2012 −$40.63M
Operating Cash Flow FY 2013 · Dec 31, 2011 −$49M
Long Term Debt FY 2013 · Dec 31, 2013 $31.92M
Long Term Debt FY 2013 · Dec 31, 2012 $34.6M
Short Term Debt FY 2013 · Dec 31, 2013 $10.08M
Short Term Debt FY 2013 · Dec 31, 2012 $5.41M
Cash And Equivalents FY 2013 · Dec 31, 2013 $29.15M
Cash And Equivalents FY 2013 · Dec 31, 2012 $25.72M
Cash And Equivalents FY 2013 · Dec 31, 2011 $33.63M
Cash And Equivalents FY 2013 · Dec 31, 2010 $82.03M
Stockholders Equity FY 2013 · Dec 31, 2013 $18.44M
Stockholders Equity FY 2013 · Dec 31, 2012 $37.6M
Stockholders Equity FY 2013 · Dec 31, 2011 $74.32M
Stockholders Equity FY 2013 · Dec 31, 2010 $118.5M
Current Liabilities FY 2013 · Dec 31, 2013 $22.95M
Current Liabilities FY 2013 · Dec 31, 2012 $22.24M
Total Liabilities FY 2013 · Dec 31, 2013 $70M
Total Liabilities FY 2013 · Dec 31, 2012 $57.16M
Current Assets FY 2013 · Dec 31, 2013 $37.75M
Current Assets FY 2013 · Dec 31, 2012 $37.78M
Total Assets FY 2013 · Dec 31, 2013 $88.44M
Total Assets FY 2013 · Dec 31, 2012 $94.76M
Eps Diluted FY 2013 · Dec 31, 2013 −$0.63
Eps Diluted FY 2013 · Dec 31, 2013 −$2.92
Eps Diluted FY 2013 · Sep 30, 2013 −$0.85
Eps Diluted FY 2013 · Jun 30, 2013 −$2.32
Eps Diluted FY 2013 · Mar 31, 2013 $0.82
Eps Basic FY 2013 · Dec 31, 2013 −$0.63
Eps Basic FY 2013 · Dec 31, 2013 −$2.92
Eps Basic FY 2013 · Sep 30, 2013 −$0.85
Eps Basic FY 2013 · Jun 30, 2013 −$2.32
Eps Basic FY 2013 · Mar 31, 2013 $0.89
Sga Expense FY 2013 · Dec 31, 2013 $12.68M
Sga Expense FY 2013 · Dec 31, 2012 $11.26M
Sga Expense FY 2013 · Dec 31, 2011 $8.76M
Rd Expense FY 2013 · Dec 31, 2013 $82.7M
Rd Expense FY 2013 · Dec 31, 2012 $69.51M
Rd Expense FY 2013 · Dec 31, 2011 $44.2M
Net Income FY 2013 · Dec 31, 2013 −$6.5M
Net Income FY 2013 · Dec 31, 2013 −$29.67M
Net Income FY 2013 · Sep 30, 2013 −$8.68M
Net Income FY 2013 · Jun 30, 2013 −$23.45M
Net Income FY 2013 · Mar 31, 2013 $8.97M
Net Income FY 2013 · Dec 31, 2012 −$9.05M
Net Income FY 2013 · Dec 31, 2012 −$42.87M
Net Income FY 2013 · Sep 30, 2012 −$3.29M
Net Income FY 2013 · Jun 30, 2012 −$20.77M
Net Income FY 2013 · Mar 31, 2012 −$9.76M
Net Income FY 2013 · Dec 31, 2011 −$48.98M
Operating Income FY 2013 · Dec 31, 2013 −$4.64M
Operating Income FY 2013 · Dec 31, 2013 −$24.44M
Operating Income FY 2013 · Sep 30, 2013 −$7.55M
Operating Income FY 2013 · Jun 30, 2013 −$22.32M
Operating Income FY 2013 · Mar 31, 2013 $10.07M
Operating Income FY 2013 · Dec 31, 2012 −$7.93M
Operating Income FY 2013 · Dec 31, 2012 −$40.34M
Operating Income FY 2013 · Sep 30, 2012 −$2.45M
Operating Income FY 2013 · Jun 30, 2012 −$20.49M
Operating Income FY 2013 · Mar 31, 2012 −$9.48M
Operating Income FY 2013 · Dec 31, 2011 −$48.56M
Revenue FY 2013 · Dec 31, 2013 $13.13M
Revenue FY 2013 · Dec 31, 2013 $71M
Revenue FY 2013 · Sep 30, 2013 $15.55M
Revenue FY 2013 · Jun 30, 2013 $2.99M
Revenue FY 2013 · Mar 31, 2013 $39.33M
Revenue FY 2013 · Dec 31, 2012 $9.21M
Revenue FY 2013 · Dec 31, 2012 $40.51M
Revenue FY 2013 · Sep 30, 2012 $15.58M
Revenue FY 2013 · Jun 30, 2012 $13.08M
Revenue FY 2013 · Mar 31, 2012 $2.65M
Revenue FY 2013 · Dec 31, 2011 $4.49M